Rafael Amado - May 1, 2023 Form 4 Insider Report for Poseida Therapeutics, Inc. (PSTX)

Role
Director
Signature
/s/ Harry J. Leonhardt, Attorney-in-Fact
Stock symbol
PSTX
Transactions as of
May 1, 2023
Transactions value $
$0
Form type
4
Date filed
5/2/2023, 04:14 PM
Previous filing
Apr 14, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX Common Stock Award $0 +39.3K $0.00 39.3K May 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PSTX Stock Option (Right to Buy) Award $0 +55.2K $0.00 55.2K May 1, 2023 Common Stock 55.2K $2.76 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issuable upon the vesting of restricted stock units ("RSUs") granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest in three successive equal annual installments following May 1, 2023.
F2 The stock option will vest and become exercisable in 36 equal monthly installments following May 1, 2023.